文献速递癫痫

要点与误区:利用新的诊断与治疗方法治疗一例遗传性药物难治性局灶性癫痫患者

Pearls & Oy-sters: Harnessing New Diagnostic and Therapeutic Approaches to Treat a Patient With Genetic Drug-Resistant Focal Epilepsy.
PubMed 文献 · Neurology · 2023-01-25

本文报告一例20岁男性药物难治性局灶性癫痫患者,携带DEPDC5 c.1555C>T(p.Gln519*)杂合致病性变异;3T脑MRI未见异常,7T MRI包括7T边缘增强梯度回波序列发现左侧额上沟沟底局灶性皮质发育不良2a型,与电临床数据一致;患者接受MR引导激光间质热消融治疗,未行颅内脑电图监测,随访9个月无癫痫发作。

要点

  • DEPDC5变异与家族性局灶性癫痫伴局灶性皮质发育不良2a型包括沟底发育不良相关。
  • 7T MRI包括7T边缘增强梯度回波序列可发现3T MRI未显示的沟底发育不良。
  • MR引导激光间质热消融治疗左侧额叶沟底发育不良后随访9个月无癫痫发作。

核心结论

  • 结合癫痫基因检测、微创手术和超高场强MRI的 summative 信息,可为遗传性药物难治性局灶性癫痫患者提供安全有效的治疗。

研究设计与样本

  • 本文为病例报告,报告一例20岁男性药物难治性局灶性癫痫患者。

主要发现

  • 患者携带DEPDC5 c.1555C>T(p.Gln519*)杂合致病性变异。
  • 初始3T脑MRI未见异常,后续7T MRI包括7T边缘增强梯度回波序列发现左侧额上沟沟底发育不良,与电临床数据一致。
  • 患者接受MR引导激光间质热消融治疗左侧额叶沟底发育不良,未行颅内脑电图监测(跳过的候选者),自末次随访以来无癫痫发作9个月。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Focal cortical dysplasia (FCD) is a congenital developmental malformation and is one of the leading causes of drug-resistant focal epilepsy (DRFE). Although focal epilepsies traditionally have been regarded as acquired disorders, increasing evidence suggests a substantial genetic contribution to the pathogenesis of focal structural epilepsies, including FCDs. Variations in the Dishevelled, Egl-10, and domain-containing protein 5 (DEPDC5) have recently emerged as a causative gene mutation in familial focal epilepsies associated with FCD type 2a, including bottom-of-sulcus dysplasia (BOSD). We present the case of a 20-year-old man with DRFE, positive for DEPDC5 c.1555C>T (p.GIn519*) heterozygous pathogenic variant. Initial 3T brain MRI was unrevealing, but subsequent 7T MRI including 7T edge-enhancing gradient echo revealed a left superior frontal sulcus BOSD concordant with the electroclinical data. The patient underwent treatment with MR-guided laser interstitial thermal ablation of the left frontal BOSD without intracranial EEG monitoring (skipped candidate), resulting in a seizure-free outcome of 9 months since the last follow-up. Our case highlights the real-world application of summative information obtained through advancements in epilepsy genetic testing, minimally invasive surgeries, and ultra-high field MRI, allowing us to provide a safe and effective treatment for a patient with a genetic DRFE.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Khan A, Middlebrooks EH, Javarayee P, et al. Pearls & Oy-sters: Harnessing New Diagnostic and Therapeutic Approaches to Treat a Patient With Genetic Drug-Resistant Focal Epilepsy. Neurology. 2023. PMID: 36697241. doi:10.1212/WNL.0000000000206900

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。